GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.234
+0.028 (13.82%)
At close: Dec 20, 2024, 4:00 PM
0.230
-0.004 (-1.67%)
After-hours: Dec 20, 2024, 7:51 PM EST

GlycoMimetics Statistics

Total Valuation

GlycoMimetics has a market cap or net worth of $15.08 million. The enterprise value is $953,267.

Market Cap 15.08M
Enterprise Value 953,267

Important Dates

The next estimated earnings date is Monday, January 6, 2025, after market close.

Earnings Date Jan 6, 2025
Ex-Dividend Date n/a

Share Statistics

GlycoMimetics has 64.48 million shares outstanding. The number of shares has increased by 6.56% in one year.

Current Share Class 64.48M
Shares Outstanding 64.48M
Shares Change (YoY) +6.56%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 3.15%
Owned by Institutions (%) 13.22%
Float 42.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.33
P/TBV Ratio 1.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 95.33
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.02.

Current Ratio 3.62
Quick Ratio 3.34
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -137.20% and return on invested capital (ROIC) is -77.67%.

Return on Equity (ROE) -137.20%
Return on Assets (ROA) -66.74%
Return on Capital (ROIC) -77.67%
Revenue Per Employee $286
Profits Per Employee -$1.14M
Employee Count 35
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.02% in the last 52 weeks. The beta is 1.78, so GlycoMimetics's price volatility has been higher than the market average.

Beta (5Y) 1.78
52-Week Price Change -89.02%
50-Day Moving Average 0.30
200-Day Moving Average 0.68
Relative Strength Index (RSI) 39.45
Average Volume (20 Days) 1,096,891

Short Selling Information

The latest short interest is 2.60 million, so 4.03% of the outstanding shares have been sold short.

Short Interest 2.60M
Short Previous Month 3.80M
Short % of Shares Out 4.03%
Short % of Float 6.07%
Short Ratio (days to cover) 1.07

Income Statement

In the last 12 months, GlycoMimetics had revenue of $10,000 and -$39.74 million in losses. Loss per share was -$0.62.

Revenue 10,000
Gross Profit 10,000
Operating Income -36.78M
Pretax Income -39.11M
Net Income -39.74M
EBITDA -36.73M
EBIT -36.78M
Loss Per Share -$0.62
Full Income Statement

Balance Sheet

The company has $14.39 million in cash and $262,133 in debt, giving a net cash position of $14.13 million or $0.22 per share.

Cash & Cash Equivalents 14.39M
Total Debt 262,133
Net Cash 14.13M
Net Cash Per Share $0.22
Equity (Book Value) 11.38M
Book Value Per Share 0.18
Working Capital 11.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.01 million and capital expenditures -$10,773, giving a free cash flow of -$35.02 million.

Operating Cash Flow -35.01M
Capital Expenditures -10,773
Free Cash Flow -35.02M
FCF Per Share -$0.54
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -367,847.59%
Pretax Margin -397,350.46%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GlycoMimetics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.56%
Shareholder Yield -6.56%
Earnings Yield -263.45%
FCF Yield -232.20%

Analyst Forecast

The average price target for GlycoMimetics is $12.00, which is 5,030.40% higher than the current price. The consensus rating is "Hold".

Price Target $12.00
Price Target Difference 5,030.40%
Analyst Consensus Hold
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GlycoMimetics has an Altman Z-Score of -37.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -37.52
Piotroski F-Score 1